Latest updates in low grade serous ovarian cancer treatment and research

Promising Advances in Low Grade Serous Ovarian CancerПодробнее

Recurrent disease | Let’s Talk About LGSOCПодробнее

Low-Grade Serous Ovarian Cancer 2023 UpdateПодробнее

Management of low-grade serous carcinoma - Prof. Nicolo BizzarriПодробнее

Webinar: LGSOC Clinical Trials For Patients & Caregivers June 2023 | Let’s Talk About LGSOCПодробнее

Being Your Own Advocate | Let’s Talk About LGSOCПодробнее

Research Update on Recurrent Low-Grade Serous Ovarian CancerПодробнее

Fertility and Family Planning | Let’s Talk About LGSOCПодробнее

Low-grade serous ovarian carcinoma (LGSOC) EL-PFDDПодробнее

Doc Talk: Premal Thaker, MD, MS on Low-Grade Serous Ovarian Cancer Research | Let’s Talk About LGSOCПодробнее

Dr Robb Hollis: ‘Towards new therapies for low grade serous ovarian cancer.’Подробнее

#Cancer #Tumor #Surgery Drug Combination is the Next Best Treatment for Ovarian Cancer PatientsПодробнее

GYNOCARE - Low grade serous ovarian cancer: so many treatment roads to follow – Prof. Aljosa MandicПодробнее

What’s the Latest in Low-Grade Serous Ovarian Cancer?Подробнее

Experts & Advocates: Low-Grade Serous Ovarian Cancer Facts & Diagnoses | Let’s Talk About LGSOCПодробнее

Latest Updates on Rare Ovarian CancersПодробнее

Ovarian Cancer Canada's Research Forum: Accelerating Progress, creating ImpactПодробнее

Low-grade serous ovarian cancer: expert consensus report on the state of the science video podcastПодробнее

Ask the Experts: towards new therapies for low grade serous ovarian cancerПодробнее

What is Low-Grade Serous Ovarian Cancer (LGSOC)? | Let’s Talk About LGSOCПодробнее